Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis : A phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL)
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-09-01
著者
-
Choi Jee-ho
Asan Medical Center
-
Tsai Tsen-fang
Department Of Dermatology College Of Medicine National Taiwan University And National Taiwan University Hospital
-
Shen Yuang-kuang
Centocor Research & Development Inc.
-
Kim Kwang-joong
Hallyam University Sacred Heart Hospital
-
HO Ji-Chen
Department of Dermatology, Chang-Gung Memorial Hospital, Kaohsiung Medical Center
-
SONG Michael
Centocor Research & Development, Inc.
-
SZAPARY Philippe
Centocor Research & Development, Inc.
-
GUZZO Cynthia
Centocor Research & Development, Inc.
-
LI Shu
Centocor Research & Development, Inc.
-
KIM Tae-Yoon
Seoul St. Mary's Hospital, The Catholic University of Korea
-
YOUN Jai-IL
Seoul National University College of Medicine
-
Li Shu
Centocor Research & Development Inc.
-
Guzzo Cynthia
Centocor Research & Development Inc.
-
Song Michael
Centocor Research & Development Inc.
-
Kim Tae-yoon
Seoul St. Mary's Hospital The Catholic University Of Korea
-
Tsai Tsen-fang
Department Of Dermatology National Taiwan University Hospital National Taiwan University College Of Medicine
-
Ho Ji-chen
Department Of Dermatology Chang-gung Memorial Hospital Kaohsiung Medical Center
関連論文
- Polymorphisms of MTHFR gene associated with livedoid vasculopathy in Taiwanese population
- Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan
- Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis : A phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL)
- Transformation of myxofibrosarcoma into myxoinflammatory fibroblastic sarcoma